Metraipolis › archive › dc_9c27fd081998

Targeting AMPK for Cancer Therapy: Metabolic Reprogramming as a Therapeutic Strategy — Europe PMC PMID:41050082

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41050082
DOI
10.32604/or.2025.067487
License (as archived)
solo-consultazione
Archived
2026-11-09T18:03:16.437Z
SHA-256 of the archived text
25fc84ad162a15f3281f3ac84997e3cc8a3d57f0b8d5e12cb07eec9300746b12
Stable URL of this page
https://metraipolis.com/documento/dc_9c27fd081998

How to cite

Targeting AMPK for Cancer Therapy: Metabolic Reprogramming as a Therapeutic Strategy — Europe PMC PMID:41050082 — Europe PMC (en), https://europepmc.org/article/MED/41050082 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9c27fd081998 (Metraipolis archive dc_9c27fd081998, sha256 25fc84ad162a15f3281f3ac84997e3cc8a3d57f0b8d5e12cb07eec9300746b12)
BibTeX
@misc{dc9c27fd081998,
  title = {Targeting AMPK for Cancer Therapy: Metabolic Reprogramming as a Therapeutic Strategy — Europe PMC PMID:41050082},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41050082},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9c27fd081998; sha256 25fc84ad162a15f3281f3ac84997e3cc8a3d57f0b8d5e12cb07eec9300746b12},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41050082. Agents can read the archived copy with the MCP tool read_document.